首页> 美国卫生研究院文献>Carcinogenesis >Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer
【2h】

Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer

机译:葡萄种子中低聚原花色素的抗癌特性的机理研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although the anticancer properties of oligomeric proanthocyanidins (OPCs) from grape seeds have been well recognized, the molecular mechanisms by which they exert anticancer effects are poorly understood. In this study, through comprehensive RNA-sequencing-based gene expression profiling in multiple colorectal cancer cell lines, we for the first time illuminate the genome-wide effects of OPCs from grape seeds in colorectal cancer. Our data revealed that OPCs affect several key cancer-associated genes. In particular, genes involved in cell cycle and DNA replication were most significantly and consistently altered by OPCs across multiple cell lines. Intriguingly, our in vivo experiments showed that OPCs were significantly more potent at decreasing xenograft tumor growth compared with the unfractionated grape seed extract (GSE) that includes the larger polymers of proanthocyanidins. These findings were further confirmed in colorectal cancer patient-derived organoids, wherein OPCs more potently inhibited the formation of organoids compared with GSE. Furthermore, we validated alteration of cell cycle and DNA replication-associated genes in cancer cell lines, mice xenografts as well as patient-derived organoids. Overall, this study provides an unbiased and comprehensive look at the mechanisms by which OPCs exert anticancer properties in colorectal cancer.
机译:尽管来自葡萄籽的低聚原花青素(OPC)的抗癌特性已广为人知,但对它们发挥抗癌作用的分子机理了解甚少。在这项研究中,我们通过在多个结直肠癌细胞系中进行基于RNA测序的全面基因表达谱分析,我们首次阐明了葡萄籽中的OPC在结直肠癌中的全基因组效应。我们的数据显示,OPCs影响几个关键的癌症相关基因。尤其是,参与细胞周期和DNA复制的基因被跨多个细胞系的OPC最显着且一致地改变。有趣的是,我们的体内实验表明,与包含较大原花青素聚合物的普通葡萄籽提取物(GSE)相比,OPCs在降低异种移植瘤生长方面的效力明显更高。这些发现在大肠癌患者类器官中得到了进一步证实,其中与GSE相比,OPCs更有效地抑制了类器官的形成。此外,我们验证了癌细胞系,小鼠异种移植物以及患者来源的类器官中细胞周期和DNA复制相关基因的改变。总体而言,这项研究对OPC在大肠癌中发挥抗癌作用的机制进行了公正而全面的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号